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Abstract
Accurate protein identification in large-scale proteomics experiments relies upon a detailed, accurate protein catalogue,
which is derived from predictions of open reading frames based on genome sequence data. Integration of mass
spectrometry-based proteomics data with computational proteome predictions from environmental metagenomic
sequences has been challenging because of the variable overlap between proteomic datasets and corresponding short-
read nucleotide sequence data. In this study, we have benchmarked several strategies for increasing microbial peptide
spectral matching in metaproteomic datasets using protein predictions generated from matched metagenomic sequences
from the same human fecal samples. Additionally, we investigated the impact of mass spectrometry-based filters (high mass
accuracy, delta correlation), and de novo peptide sequencing on the number and robustness of peptide-spectrum
assignments in these complex datasets. In summary, we find that high mass accuracy peptide measurements searched
against non-assembled reads from DNA sequencing of the same samples significantly increased identifiable proteins
without sacrificing accuracy.
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Introduction
Key questions in environmental microbiology include: (i) what
microorganisms are present in a particular environment, (ii) how
are they functioning, and (iii) how does community structure and
function vary in response to environmental conditions/changes?
Recent technological advances have provided powerful experi-
mental approaches to address these questions, with 16S rRNA-
based taxonomic profiling providing extensive information about
microbial composition, and metagenomic whole-genome shotgun
(WGS) sequencing/shotgun community proteomics, or ‘‘metapro-
teomics,’’ providing insights into the composition and functional
activities of microbial communities. In particular, metagenome
sequencing with next-generation platforms has revolutionized the
ability to measure and fully characterize the genomic repertoire in
microbial communities.
In order to successfully identify peptide sequences using mass
spectrometry (MS)-based proteomics methods, a relevant database
of predicted genes derived from genome or metagenome sequen-
ces is necessary. Peptide identifications result from matching
tandem mass spectra (MS/MS) against predicted fragmentation
patterns of all possible in silico digested peptides using well-
established programs [1,2,3]. Therefore, successful MS/MS
sequence-database searching is critically dependent on the quality
and accuracy of the metagenomic predicted sequence database.
Although traditional MS-based proteomic analyses of single
bacterial isolates are well established, applying these methods to
complex microbial communities can be challenging for several
reasons, including the lack of deep sequence coverage and diffi-
culty in assembling metagenomes from 454-reads. Considerable
improvements in mass spectrometers and chromatography have
been made over the past decade; however, the development of
tools for optimizing metagenome-metaproteome sequence match-
ing has not kept pace, especially when using the shorter sequence
reads associated with next generation sequencing platforms such as
the 454 pyrosequencer [4] and Illumina GAII [5].
While an increasing number of studies have developed com-
putation methods for proteogenomics [6,7] and begun to inte-
grate metagenomic sequence data with proteome measurements
[8,9,10], these studies have primarily focused on either single
eukaryotic genomes or populations with low diversity, allowing for
sufficient depth of sequence coverage of abundant community
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more complex microbial communities (e.g., human microbiome,
ocean, and soil). In the human distal gut, there are approximately
1,000 estimated species which represent .7,000 prokaryotic
strains; therefore, the complete metagenome is estimated to be
.100 times the size of the human genome [11]. Based on previous
studies of these exact same samples, we would expect ,30% of the
proteins identified by proteomics to be of human origin [12]. The
challenges inherent in a metagenomic-metaproteomic character-
ization of complex environmental samples include (i) considerable
sequence diversity among closely related strains/species, (ii) large
number of organisms for which no reference genome sequence is
available and (iii) low nucleotide sequence coverage for the
microorganisms, especially low abundance members.
Here we present a benchmarking of strategies for integration of
metagenomic and metaproteomic data derived from the same
human gut microbiome samples. Although the metagenomes were
not sequenced to saturation, they were sufficient to enable us to
evaluate how protein predictions based on metagenome data
impact peptide-spectrum assignments in matched metaproteomic
datasets (i.e., metagenome and metaproteome of the exact same
sample). Using 454 pyrosequencing, 1,079 Mbp of DNA sequence
was obtained from two fecal samples obtained from a pair of
healthy twins [13]. Using these data, four protein sequence
databases were created using several different assembly and gene
finding strategies (Fig. 1). The resulting databases were evaluated
for their utility in MS sequence-database searching.
Assembly of metagenomic reads can potentially generate errors
by joining sequence reads that share sequence identity but are
derived from different strains or species. This can be further
complicated by sequencing errors, such as issues with homopol-
ymer tracts in 454 pyrosequencing datasets [14,15]. The meta-
genome assembly strategies examined in this study were (i)
assembly by sample, exemplifying the traditional approach used
for single isolate genomes, (ii) whole-dataset assembly, in order to
increase sequence coverage, and (iii) no assembly, which will
theoretically capture all sequence diversity present in a sample.
Since sequencing errors can also introduce frameshifts and in-
frame stop codons, resulting in fragmented gene predictions, we
explored homology-based gene finding, as it allows the ability to
‘gap’ over sequencing errors, and de novo based gene finding which
uses models of known gene structure for prediction.
Proteomics approaches were also benchmarked to identify the
parameters necessary to create accurate peptide-spectrum matches
(PSMs; a match of a given MS/MS spectrum to a specific database
peptide sequence) and increase protein discovery by de novo peptide
sequencing. Several MS-related parameters (spectral quality, delta
correlation (deltCN), and high mass accuracy (610 ppm (parts-
per-million)) were examined and proved to be helpful in providing
more comprehensive, confident PSMs. Moreover, we investigated
how much de novo peptide sequencing would increase peptide
identification, since it provides novel sequences that were not
originally present in the sequence database (e.g., polymorphisms).
By utilizing the genomic and proteomic tools described in this
study, we identified a strategy that increased the number of PSMs
and protein identifications in a complex microbial community that
can provide a more comprehensive and accurate characterization
of the human gut microbiome.
Methods
Samples, DNA and Protein Extraction
Fecal samples from two healthy female human individuals (a
concordant twin pair), numbered 6a and 6b, were collected under
a separate study, as described and studied previously [12]. Both
samples were used for DNA and protein extraction. An additional
three twin pairs corresponding to six human fecal samples:
numbered 15a and 15b (concordant pair with Crohn’s disease),
16a and 16b (discordant pair, healthy 16a and 16b with Crohn’s
disease), and 18a and 18b (discordant pair, healthy 18a and 18b
with Crohn’s disease), were used for metagenomic sequencing only
and were included in several of the sequence databases as
described in ‘‘Protein Database Construction.’’ Therefore, a total
of two healthy samples (6a and 6b) were used for metaproteomics
and eight (four healthy: 6a, 6b, 16b, and 18b and four diseased:
15a, 15b, 16a, 16b) samples were used for metagenomics.
Throughout the manuscript, the diseased samples and individuals
other than 6a and 6b are referred to as ‘‘unrelated’’ because we are
only focusing on 6a and 6b samples’ metaproteomes, thus, we have
a ‘‘matched’’ or ‘‘related’’ metagenome-metaproteome. Since
these fecal samples were collected under a separate research
program and were supplied as de-identified information for this
study, this work was approved in March 2010 by the Oak Ridge
Site-wide Institutional Review Board (ORSIRB; Dr. Leigh
Greeley, chair-person) as ‘‘human studies exemption 4’’, IRB
REFERENCE #: ORNL EX(10)-3.
Total genomic DNA was extracted using the MoBio PowerSoil
DNA Isolation kit (MoBio Laboratories, Carlsbad, CA) following
the manufacturer’s recommendations. Sample 6a was also
extracted using the Zymo extraction protocol recently published
by Ravel and colleagues [16]. Each sample was then sequenced
using Roche 454 FLX-Titanium pyrosequencing according to
Figure 1. Creation of protein sequence databases. Protein sequence databases were created from metagenomic sequence reads using a
variety of methods for assembly and gene finding.
doi:10.1371/journal.pone.0027173.g001
Strategies for Metagenomic-Guided Community Proteomics
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27173manufacturer specifications. Raw sequence data were processed
using the Roche/454 run processing software to filter short,
mixed, and low quality reads. The sequencing generated 418K
2627 M passed-filter reads and 170–381 Mbp per sample for the
eight human fecal samples (15a, 15b, 16a, 16b, 18a, 18b, 6b, and
6a). Microbial cells (,100 mg cell pellet) and proteins were ex-
tracted and processed for two-dimensional liquid chromatography
coupled to tandem mass spectrometry (2D-LC-MS/MS). The pro-
tocol for cell lysis and protein extraction has been rigorously tested
and developed by our laboratory [17,18] with specific details
corresponding to these samples detailed in Verberkmoes et al. [12].
Protein Database Construction
Starting with 454 pyrosequencing reads, four metagenomic
processing methods (NM, RM, RFM, and CAFM, see below for
definitions) were evaluated for the construction of predicted
protein databases (Fig. 1 and Table 1). Sequences were first filtered
for human contamination by alignment of reads to the human
genome (v 36) using NUCMER [19] using default parameters.
The Newbler-Metagene (NM) protein sequence database was
created using the single-genome strategy by generation of a de novo
assembly followed by de novo gene finding. While there are a variety
of gene prediction algorithms available, we chose to focus on
MetaGene Annotator [20], a platform that we have extensive
experience with for 454 sequencing datasets. Certainly, newer
approaches, such as Orphelia [21], MetaGeneMark [22], and
FragGeneScan [23] have appeared and shown promise for
Illumina datasets; however, the accuracy of these algorithms do
not appear to differ greatly for 300–400 bp reads and thus we
preferred to utilize our more rigorously tested MetaGene version.
Shotgun sequences from each sample were assembled using the
Newbler Assembler (v2.0.01.14), and genes were predicted on
contigs greater than 500 bp using Metagene [24], resulting in a
total of 153,586 predicted open reading frames (ORFs) larger than
50 nt across a total of the seven metagenome samples included in
this study. The second database, Reads-Metagene (RM), was
created by directly predicting ORFs from raw sequencing reads to
prevent loss of sequence diversity when collapsing unrelated
sequencing reads during genome assembly. ORFs were predicted
using Metagene, yielding 1,866,893 predicted ORFs larger than
50 nt. Sequencing errors often seen in pyrosequencing datasets
[14,15] can lead to artificially fragmented predicted ORFs.
Because these errors cause frameshifts and in-frame stop codons
in gene predictions, we used protein-to-DNA alignments, gene-
rated by sequence similarity searches against NCBI’s NR using
FASTX [25] with an expectation value threshold of 1e
26,t o
predict genes by homology. Homology-based gene finding was
performed on raw 454 sequencing reads yielding 1,483,958
predicted ORFs larger than 50 nt, called Reads-FASTX-Meta-
gene (RFM) protein database.
Additionally, three databases were created from assembled
reads, with the intent of creating longer genes and fewer protein
fragments. The combination of short sequencing reads, averaging
369 bp, and the high bacterial diversity found in the human gut,
produced a dataset with many fragmented genes. Since assembled
sequences were not much longer than raw sequencing reads, these
genes were also fragmented, therefore, we were unable to validate
proteins identified by multiple peptide matches. Thus, an assembly
was created by combining the shotgun sequence data from these
samples using the Celera Assembler (v5.4), called Celera
Assembler-FASTX-Metagene (CAFM), yielding 1,807,963 pre-
dicted proteins on all contigs and singletons larger than 50 nt.
Homology-based gene finding was also used for this CAFM data-
base, using the same parameters as RFM. In addition to sequences

























Database Acronym CAFM NM NM_KG RM RFM RFM_KG RMPS
Number of Sequences (thousand) 1,844 190 540 1,903 1,520 1,907 2,146
Number of Amino Acids (million bp) 200 45 115 189 173 262 191
Compute Time Per Run (minutes) 670 80 320 750 1,060 1,030 435
Number of Non-redundant
Spectra
6a Run 2 5,179 6,235 10,441 9,100 9,074 10,975 13,806
6a Run 3 4,326 5,376 9,272 8,152 8,538 10,330 18,401
6b Run 1 4,092 5,615 10,830 8,639 8,480 11,254 12,363
6b Run 2 3,873 5,800 10,724 8,775 8,573 11,167 12,212
Total Spectra 17,470 23,026 41,267 34,666 34,665 43,726 56,782
Total number of PSMs within 610 ppm 14,317 16,906 31,289 26,181 25,997 33,347 39,681
Number of Non-redundant
Peptides
6a Run 2 4,383 3,093 5,678 4,710 4,669 5,911 7,592
6a Run 3 3,655 2,403 4,617 3,804 3,963 5,068 6,303
6b Run 1 3,404 2,426 5,409 3,919 3,879 5,549 5,923
6b Run 2 3,216 2,297 5,088 3,747 3,690 5,238 5,605
Total Peptides 14,658 10,219 20,792 16,180 16,201 21,766 25,423
Total NR Peptides 8,632 5,994 12,406 9,618 9,608 13,111 16,055
The database composition and SEQUEST/DTASelect search results (compute time, identified non-redundant spectra and peptides) with a 2-peptide and deltCN of 0.08
filters are shown for samples 6a (Run 2 and 3) and 6b (Run 1 and 2).
doi:10.1371/journal.pone.0027173.t001
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human gut metagenomic datasets: two metagenomes from Gill et
al. [26] and thirteen metagenomes from Kurokawa et al. [27], that
were concatenated with the NM (termed NM_KG) and RFM
(termed RFM_KG) sequence databases to provide additional
sequence variation and increase proteome coverage. The meta-
genomes published from Gill et al. [26] (17,688 contigs; ORFs $20
amino acids; ,50,000 predicted proteins; available at the Joint
Genome Institute (JGI) IMG database under NCBI project ID
16729) and Kurokawa et al. [27] (81,968 contigs; ORFs$50 amino
acids; ,300,000 predicted proteins; available at CAMERA (2007))
studies were sequenced via Sanger-based methods. The amino
acid sequence of the proteins belonging to the two samples’
metagenomes used in this study (6a and 6b in addition to 15a, 15b,
16a, 16b, 18a, 18b) can be accessed through the NCBI Protein
Database under NCBI project ID 46321.
For each of the protein sequence databases described above
(NM, CAFM, RFM, NM_KG, and RFM_KG), we concatenated
the metagenomic protein predictions from multiple individuals
into a single database. For example, NM, RM, RFM, and CAFM
each contain metagenomic sequences from seven individual
human samples from this study (15a, 15b, 16a, 16b, 18a, 18b,
and 6b), which include an unrelated healthy sample 16b (Figure 2
comparisons). The NM_KG and RFM_KG protein databases
contain the same 7 metagenomic predicted protein sequences
(15a, 15b, 16a, 16b, 18a, 18b, and 6b), but unlike NM and RFM,
contain the published 13 Japanese metagenome sequences [27]
and 2 American metagenome sequences [26] for a total of 22
concatenated metagenomes per protein sequence database.
Deeper whole genome shotgun sequencing was obtained from
an extra run on 6b and an additional sample (6a), extracted using
the Zymo and MioBio method, which resulted in a four-fold
increase in sequence data for these two healthy samples (Table S1).
Due to the limitations of analyzing this larger metagenomic
sequence dataset, these sequences were processed similar to the
RM strategy and compiled into 2-independent protein databases,
termed RMPS, for 6a and 6b in this assessment. Each of these 8
protein databases (NM, NM_KG, CAFM, RFM, RFM_KG, RM,
RMPS-6a and RMPS-6b) included human reference sequences
(July 2007 release, NCBI; ,36,000 protein sequences) and
common contaminants (i.e., trypsin and keratin; 36 protein
sequences). Lastly, a 6-frame translation library was generated
for sample 6a and searched against one MS experiment.
Spectral Analysis
Microbial proteins were extracted and processed for 2D-LC-
MS/MS as described [12] using an Ultimate HPLC system
(Dionex, Sunnyvale, CA) coupled to a high resolution LTQ-
Orbitrap (Thermo Fisher Scientific, San Jose, CA). Peptide
mixtures from the two samples, 6a and 6b, were separated by a
12 step, multidimensional high-pressure liquid chromatographic
elution profile consisting of eleven salt pulses followed by a 2 hr
reverse-phase gradient from 100% solvent A (A: 95% H2O, 5%
acetonitrile, 0.1% formic acid) to 50% solvent B (B: 30% H2O,
Figure 2. Comparison of identified peptides using sequence similarity techniques. Percentage of matches found when comparing
identified peptides from sample 6a (left panel) or 6b (right panel) to predicted proteins using FASTS (gray bars) and raw sequencing reads using
TFASTS (white striped bars).
doi:10.1371/journal.pone.0027173.g002
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(from 400–1700 m/z) were acquired in the Orbitrap with
resolution=30,000 followed by five data-dependent MS/MS
scans at 35% normalized collision energy in the LTQ with
dynamic exclusion enabled. All RAW files were converted to
mzXMLs using ReAdW (v4.3.1; 2009) and mzXMLs subsequently
converted to dta files using MzXML2Search (v4.3.1; 2009). All
MS/MS were searched with SEQUEST (v.27) [2] for fully tryptic
peptides (#4 missed cleavages, 3 Da parent mass tolerance
window, 0.5 Da fragment ion window) against each of the 8
custom-made FASTA formatted protein sequence databases
described above. Since it is well established that trypsin cleaves
primarily C-terminal to Arg and Lys [28], we have found in a
variety of microbial communities [9,29,30] that using fully tryptic
searches provides increased confidence in the peptide assignments
while minimizing the potential for increased false positives due to
incorrect candidate peptide sequences. All SEQUEST output files
were assembled and filtered using DTASelect (v1.9) [31] at either
a 2-peptide level for all seven: NM, NM_KG, RM, RFM_KG,
RFM, CAFM, and RMPS databases and also 1-peptide level for
the RMPS database searches with the following widely accepted
parameters: cross correlation scores (XCorr) of at least 1.8, 2.5, 3.5
for +1, +2, and +3 charge states [9,31,32], respectively and a
minimum deltCN of either 0.08 (default) for all seven databases
(NM, NM_KG, RM, RFM_KG, RFM, CAFM, and RMPS
databases) and/or 0.0 for NM, NM_KG, RFM, RFM_KG,
RMPS-6a and -6b, and target-decoy databases (described under
‘‘false discovery rates’’). Post-translational modifications and other
fixed modifications were not included in the search criteria.
We used the high mass accuracy capabilities of the Orbitrap
with a wide mass tolerance to measure precursor ion (peptides)
masses at low parts-per-million (ppm) and the ion trap to efficiently
measure fragment ions at lower resolution. A ‘‘post-database
search’’ filter with high precursor mass accuracy was used by
comparing the theoretically derived peptide from the SEQUEST
mass with what was observed in the Orbitrap in the full scan
preceding the MS/MS scan. Recently, Hsieh et al. [33] indicated
that a wide precursor mass window in a database search and a
post-database high precursor mass accuracy filter is a more
superior method to control false positives. Therefore, for post-
filtering the database results by high mass accuracy, the mass
deviation (in ppm) of a PSM was calculated using the measured
monoisotopic mass and theoretical monoisotopic mass of the
peptide. For all of the database searches (NM, NM_KG, RM,
CAFM, RFM, RFM_KG, RMPS-6b and -6a, and target-decoy
databases) and comparisons, DTASelect was run with a t0 option
to report all MS/MS spectra, in which case two spectra per
protein, rather than two peptides, are required for identification.
We compared each of the database results in a relative fashion
such that all comparisons (degenerate peptides) are consistent to
one another. Every MS/MS spectrum that is assigned to a peptide
(unique and non-unique peptides) was noted and handled by
DTASelect as described [31]; therefore, we recognize peptides that
are shared (non-unique) among multiple proteins. While we
recognize that non-unique peptides are somewhat problematic for
label-free quantification using spectral counts, this was not the
focus of the current study.
Spectral quality assessment was accomplished utilizing an in-
house developed script that parses the SEQUEST output and
mzXML formatted spectral data. All spectra collected during an
analysis were categorized according to type: full MS scan (MS1) or
tandem mass spectra (MS/MS). MS/MS spectra assigned to a
peptide by SEQUEST were noted while the remaining unassigned
MS/MS spectra were classified as high-quality or poor based on
the following conditions: a. the charge state of the parent ion must
be greater than 1, b. the minimum absolute intensity must be
greater than 2500 counts, and c. greater than three fragment peaks
within 20% of the based peak must be present (all other details in
preparation to be submitted for publication). To quantify the
peptide-spectrum success, MS/MS were categorized as (i) assigned
or unassigned to a peptide and (ii) if unassigned, a score of high-
quality or poor as reflected by four methods (NM, CAFM, RFM,
and RMPS) and six databases (NM, CAFM, RFM, RFM_KG,
and RMPS-6a and -6b).
All MS .raw files or other extracted formats and supporting
information are available upon request. The acquired raw MS
data associated with this manuscript may be downloaded from
ProteomeCommons.org Tranche network through www.proteo-




A target-decoy database [34,35] was generated for each of the
five metagenomic processing methods (NM, CAFM, RM, RFM,
RMPS), for a total of six forward-reverse databases (RM, RFM,
CAFM, KG, NM_KG, and RMPS-6b) and searched against one
of the two samples (6b) used in this study to estimate the peptide-
level false discovery rate (FDR) with the new metagenomic
processing methods. One sample and technical run (6b, Run1) was
used to represent the entire sample set (2 samples; 4 runs) for each
target-decoy database search in order to reduce the total number
of target-decoy databases, search time, and complexity of com-
parisons. All target-decoy SEQUEST output files were assembled
and filtered using DTASelect (v1.9) [31] with the same XCorr
filters as described previously, and either a $1 peptide per protein
with a deltCN filter of 0.0, or a $2 peptide per protein with a
deltCN of 0.0 (RMPS-6b) or 0.08 (NM_KG, CAFM, RM, RFM,
and KG), with an empirical FDR threshold of #2.0%. The initial,
1-peptide filter and deltCN 0.0, forward-reverse database searches
provide FDRs for NM_KG, CAFM, RM, RFM, KG, and RMPS-
6b (read-based) database analyses while the latter, 2-peptide and
deltCN 0.08 filter, forward-reverse database searches contain the
same filtering criteria as the original forward databases (NM,
NM_KG, RM, RFM_KG, RFM, CAFM, and RMPS databases;
Table 1 results) described earlier. Finally, a forward-reverse
database was also created for the final paired metagenome
sequence strategy (RMPS) for 6b and searched against the spectra
collected from 6b, Run 1 and Run 2 using a deltCN 0.0, 1-peptide
minimum, and high mass accuracy filtering. The identified
peptides (both forward and reverse) were then mapped back to
the protein sequences derived from the assembled metagenomic
sequences using a post-database 2-peptide filter by exact string
comparisons. Although the peptides with corresponding high mass
accuracy measurements (610 ppm) were considered for all
downstream analyses, the peptide-level FDRs were estimated for
both, with (210#ppm#10) and without (ppm , -10 and ppm .
10) high mass accuracy, for 6b, Run1 against six genomic
processing methods (NM_KG, CAFM, RM, RFM, KG, and
RMPS-6b). Each protein entry (sequence) was reversed, i.e., the
original N-terminus became the C-terminus. The new reverse
(false) sequences were then appended onto the backend of the
original forward sequences where each set, forward and reverse,
represents 50% of the entire database. A peptide-level FDR was
calculated based on the calculation: 2[nrev/(nrev + nreal)]*100
where nrev is the number of peptides identified from the reverse
database and nreal is the number of peptides identified from the
real (forward) database [35].
Strategies for Metagenomic-Guided Community Proteomics
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Peptides obtained from our SEQUEST/DTASelect searches
were searched against the 6b and 16b protein databases using
FASTS and against raw sequencing reads using TFASTS [36],
using an e-value cutoff of 10
-5.
De novo Sequencing of Peptides by MS
PepNovo+ [37] and PEAKS [38] algorithms were used to de
novo sequence MS/MS spectra collected from both samples,
independent of all sequence databases. The PEAKS (v4.5 SP2)
algorithm computes the best possible sequence among all probable
amino acid combinations at a full peptide length confidence
followed by individual amino acid confidence per residue in the
predicted sequence for a MS/MS. PEAKS was run with default
parameters with a parent mass error tolerance of 0.5 Da, fragment
mass error tolerance of 0.5 Da, and trypsin digestion. First, a 90%
confidence level was required for the overall, full length prediction
to be correct and second, an 80% confidence level was required
for each residue within that sequence, which is consistent with Ma
et al. [38] PepNovo+ (v3.1) was executed using the following
recommended parameters: -model CID_IT_TRYP -digest TRYP-
SIN -pm_tolerance 0.05 -num_solutions 5 -output_cum_probs.
The top-scoring tags of all spectra were filtered using a cumulative
probability cutoff of 0.5. In the sequence tags produced from both
algorithms, the isobaric amino acid pair of Isoleucine (I) and
Leucine (L) and the nearly isobaric pair of Lysine (K) and
Glutamine (Q) are considered equivalent. L and I were both
substituted with the letter, J, for convenience. Additionally, Q and
K were substituted with the letter, U, since they are not easily
resolvable (small mass difference of 0.036 Da) with ion trap MS/
MS data. For all three algorithms, SEQUEST, PEAKS, and
PepNovo+, a minimum of 3 residues has to be assigned to a
spectrum for it to be considered for any additional analysis and
comparison to other algorithms. For PEAKS, only the high
confidence sequence tag was used for all analyses, not the
predicted full-length peptide sequence. For the comparison of
PSMs between all three algorithms, a ‘‘partial’’ consensus sequen-
ce was considered as a peptide sequence that has $3 amino acids
that are exactly the same for the same mass spectrum between
either SEQUEST peptide sequences, Peaks’ high confidence
sequence string, and/or Pepnovo+s’ sequence tag. If a PSM has an
‘‘exact’’ consensus sequence with 100% sequence identity between
any two or more algorithms, it would be considered a shared,
exact consensus sequence. If a PSM does not have at least 3
residues within a peptide sequence string that match two or more
algorithms, that spectrum would be considered unique to that
algorithm. The identified SEQUEST/DTASelect PSMs for
RMPS-6a and -6b sequence databases with a 1-peptide minimum
and deltCN of 0.00 for 6a (Run 2 and 3) and 6b (Run 1 and 2)
were compared to the PSMs from PEAKS and PepNovo+. The
breakdown of partial and exact consensus sequences versus PSMs
that are unique to a specific algorithm can be found in the Venn
diagram. We did not take into account any single amino acid
polymorphisms in the algorithms’ consensus sequence compari-
sons. In this study, we controlled the false discovery rate by only
using the high confidence consensus sequences tags found between
the two de novo algorithms using their respective optimum
parameters.
Results
Protein Sequence Database Comparison
Four protein prediction strategies (Fig. 1) were implemented for
metagenomic DNA sequences obtained from two healthy human
fecal samples (referred to as 6a and 6b), using a combination of
assembly and gene prediction methods. Each protein sequence
database has a defined acronym (2–4 letters), designating the
strategy used (Fig. 1 and Table 1). Our goal was to increase
peptide-spectrum matches using MS database searching for which
the MS data was collected from the same samples as the DNA
sequence data. The ability to accurately match peptides to tandem
mass spectra (MS/MS) was assessed by comparing the number of
PSMs and unique peptides identified for each database search with
SEQUEST/DTASelect at a 2-peptide level, deltCN 0.08, and
XCorr filtering against the same 2 samples, 6a (with spectra from
runs 2 and 3) and 6b (with spectra from runs 1 and 2) (Table 1).
These results illustrate how common metagenomic processing
methods (assembly and ORF finding) affect peptide and spectra
identification (Table 1). From these results, three major trends
emerge: (A) Collapsing of the sequence data by assembly decreases
the number of assigned spectra. There was a decrease of assigned
spectra when all reads were assembled from all samples compared
to assembly by individual sample (NM, 23,026 spectra vs. CAFM,
17,470 spectra). Additionally, if reads are annotated without
assembly, PSMs increase (NM, 23,026 spectra vs. RM, 34,666
spectra). This can be largely attributed to the increased diversity of
possible peptides, determined by in silico trypsin digestion, in the
unassembled data, which is over 3 times what is found in
assembled data (5,638,100 vs. 1,639,802). (B) An increase in
spectrum assignment usually translates to an increase in unique
peptide identifications. For example, the 11,640 gains in spectral
assignment translate to a 3,624 gain in identification of unique
peptide sequences for RM compared to NM (Table 1). However,
this was not observed when comparing CAFM to NM, where the
5,556 gains in spectra assignment translated to a decrease of 2,638
unique peptides (Table 1). (C) De novo gene finding methods are
sufficient for optimal spectrum assignment. The combined de novo
and homology-based gene finding method did not increase PSMs
as hypothesized (RFM, 34,665 spectra vs. RM, 34,666 spectra) nor
the number of identified unique peptides (RFM, 9,608 peptides vs.
RM, 9,618 peptides; Table 1).
Because of the low relative sequence coverage of our meta-
genomic samples, we wanted to evaluate whether adding meta-
genomic sequences from 15 unrelated samples in two published
studies would enhance our spectrum assignment. Therefore, to
protein databases NM and RFM, we added the proteins sequences
from predicted ORFs from two published human gut metage-
nomic studies, referred to as ‘‘KG’’ for Kurokawa et al. and Gill et
al. [26,27], which are referred to as NM_KG and RFM_KG
respectively. The KG database contains 13 metagenomes from a
Japanese cohort [27] and 2 metagenomes from an American
cohort [26], both geographically distinct from samples in this
study. When compared to the metagenomic sequences in this
study, only 9% of sequences align in KG at 99% identity or
greater; thus, they provide over 2 million additional unique
peptides for MS/MS assignment, that are not identified in any of
the matched metagenomes. Because the assemblies from these
studies are on average longer (average contig length of 2,300 nt for
Kurokawa et al. compared to an average contig length of 1,128 nt
in this study), the predicted proteins are more likely to be full-
length compared to ORFs in this study (average protein length of
194.5 amino acids (aa) for Kurokawa et al. metagenomes; average
protein length of 225 aa for Gill et al. metagenomes compared to
an average protein length of 168.5 aa in this study). By including
metagenomic sequence from additional sources [26,27], the
number of identified spectra increased (NM versus NM_KG
(23,026 versus 41,267 spectra) and RFM versus RFM_KG (34,665
versus 43,726 spectra)) for 6a (Run 2 and 3) and 6b (Run 1 and 2)
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came at the cost of increased peptide degeneracy and subsequent protein
redundancy (i.e., peptides mapping to multiple proteins or to the
same protein in multiple metagenomes within the sequence
database). Although the level of redundancy ranges with the
sequence diversity of a sample and has no effect on the actual
database search algorithms, this complicates protein inference and
assigning its’ corresponding phylogenetic origin in a complex
environmental community.
While the four metagenomic processing methods were compared
based on their ability to comprehensively assign all collected MS/
MS spectra to peptides, the percentage of assigned and high-quality
unassigned MS/MS is equally important to establish the utility of
each sequence database. For the following spectral analyses, the
collected and assigned spectra from sample 6a (Run 2 and 3) and 6b
(Run 1 and 2) wereassessed and categorized after applying the same
filters described above (2-peptide level and deltCN 0.08 filter) with
the following databases. Of the total MS/MS collected during one
MS experiment (70,000–81,000), on average 6,600 spectra were
assigned to a peptide sequence in the NM database (,8% of total
collected MS/MS spectra for a single run; Table S2). In contrast,
the processing strategy used to create RFM resulted in the
assignment of an additional 1,800 MS/MS from the same sample,
for a total of 8,430 peptide-spectrum matches on average (11% of
total collected MS/MS). Furthermore, the addition of unrelated
KGsequencestoRFM(a25%increaseinsequencedata)resultedin
anincreaseofthenumberofassigned spectra byonly2–3%.Finally,
the strategy used to create RMPS resulted in an additional
4,000 MS/MS spectra assigned, for a total of 12,461 peptide-
spectrum matches on average per sample (16% of total collected
MS/MS spectra). Although the total number of assigned MS/MS
increased from NM , RFM, RFM_KG, RMPS, the numberof
unassigned, high-quality spectra decreased with database quality
(NM . RFM . RFM_KG . RMPS).
The effectsof two commonfiltering parameters(deltCNand high
mass accuracy) on MS/MS peptide assignment were examined by
determining the quantity of MS/MS spectra not assigned to the
same peptide in multiple database searches (Text S1). These results
(Figure S1) suggest that filtering on high mass accuracy rather than
deltCN can decrease ambiguous peptide-spectrum matches and
provide more consistent and reproducible MS/MS identifications.
In order to maintain high specificity and accuracy with increasing
metagenomic sequence data, a FDR was estimated at the peptide
level using an established method of reverse database searching
[34,35] for each metagenomic processing method for a total of 6
target-decoy databases (RM, RFM, CAFM, KG, NM_KG, RMPS-
6b). Because we are using methods that directly measure peptides,
not proteins, the FDR was estimated at the peptide level. In
addition, we are primarily comparing the performance of all
databases by peptide-spectrum matches, not proteins, given the
nature of the metagenomic processing methods and their
corresponding databases (i.e., not all databases contain assembled
contigs, but only reads). It has previously been noted [39] that false
discovery rates can be difficult to accurately determine with
metaproteome datasets due to problems associated with massive
peptide degeneracy. We concur with this difficulty in accurately
quantifying FDRs for metaproteomes and thus have carefully
evaluated how we might handle this issue, as defined in the
following discussion. In this study, for example, of all the identified
peptides for 6a (Run 2), only 7–30% were unique peptides from
each database. Consequently, if only unique peptides are used, the
false discovery rate would be overestimated; on the contrary, if all
peptides are used the false discovery rate could be underestimated
[39]. Therefore, to set a static FDR threshold and filter multiple
databases (6 sequence databases in this study) of different sizes and
internal levels of peptide redundancy to that threshold (i.e., 1%)
becomes a challenge, in this case, for comparing and identifying
the best metagenomic processing method for MS/MS database
searching and peptide-spectrum matching. As the level of redun-
dancyaffectstheFDR,wehavechosenasetoffixedscoringfiltersin
order to accurately compare database assignments. Thus, the same
filter criteria (i.e., Xcorr and ppm filtering) was applied to all
database searches and with a requirement that the FDR be less than
or equal to, i.e., 2.0%. The FDRs for the 1-peptide level, deltCN
0.0, with and without HM filtering were 1.17%–2.03% and 16.09–
31.47%, respectively for 6b, Run 1 (Table S3). The 2-peptide level
and deltCN 0.08 filtered reverse database searches serve to
represent the FDR of peptide identifications found in Table 1.
The FDRs for these PSMs, with and without HM filtering were
within 0.09%–0.38% and 2.17–4.15%, respectively for 6b, Run 1
(Table S4). Following the application of a post-database high
precursor mass accuracy filter (6 10 ppm) to both, the 1- and 2-
peptide filtered forward-reverse datasets, the number of identified
reverse peptides decreased by, on average, 93% for each database
which resulted in a reduction of the FDR to 0.09%–0.38%.
Tracking Missing Peptides
By adding the unrelated KG metagenomic sequences to the
RFM protein database, the number of additional predicted unique
peptide sequences increased by 40%. Therefore, we wanted to
determine how many additional peptide-spectrum matches were
gained by adding these KG proteins sequences to the database.
The RFM_KG assigned MS/MS were distributed into three
different categories: RFM only, KG only, and RFM plus KG
(shared) for each sample (Table S5 and Text S1). The majority of
RFM_KG assigned spectra were ‘‘shared’’ between both RFM
and KG protein sequences. About 26% of the total spectrum
assignments were unique to the RFM protein sequences (zero
overlap with KG sequences) and only ,8% of the spectra were
unique to the KG protein sequences (no overlap with the RFM
sequences) (Table S5).
There are two possible hypotheses for why the metagenomes
from these samples (i.e., RFM) cannot be used to assign peptides to
spectra which are assignable by the unrelated protein database
KG: (1) because of low sequencing depth, peptides are not
assigned because our protein database is incomplete or (2) because
of a sequencing error or limitation for predicting ORFs, we are
unable to predict the proteins that are present. Therefore, we have
aligned the RFM_KG (2-peptide, deltCN 0.08, HM filtered)
identified peptides (Fig. 2, y-axis) from 6a (left panel) or 6b (right
panel) to predicted raw reads from the related/same sample (6b) and
an unrelated sample (16b) (Fig. 2, x-axis) using TFASTS [36] (Fig. 2,
white, fine striped bars). Those results were compared to
alignments of the same identified peptides to the predicted protein
database from the related/same sample (6b) and the unrelated
sample (16b) using FASTS [36] (Fig. 2, gray, solid bars). As
expected, more peptides mapped to the related/same (matched
metagenome-metaproteome) sample (15% for 6a: left panel, Fig. 2
and 6b: right panel, Fig. 2) than to the unrelated, 16b, predicted
protein sequences (8% for 6a and 10% for 6b). When these same
peptides were compared using TFASTS [36] (algorithm that
compares peptides to DNA sequence) to the raw sequencing reads
(Fig. 2, white, fine striped bars), the number of peptides matching
to reads increased by two-fold for both 6a and 6b.
Targeting Peptide Discovery
Throughout the course of our study, we were able to accu-
mulate more metagenomic sequence data for the two healthy
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Although this increase in predicted ORFs resulted in an increase
in the number of assigned MS/MS spectra, it can reduce the
throughput of MS/MS sequence-database searching. Therefore,
we investigated the impact of searching a metagenomic-based
protein database derived from the exact same single sample to that
of a concatenated sequence library of all available metagenomic
data from this study. The additional metagenomic sequences were
used to construct a sequence database similar to that of RM (non-
assembled reads with 5.6 million predicted unique peptides), called
RMPS (Fig. 1) which has , 1.3 million predicted unique peptides,
on average, per healthy sample 6a and 6b. Searching the RMPS
sequence databases with SEQUEST using standard 2-peptide,
deltCN 0.08, and high mass accuracy filtering decreased the
compute time to ,300–500 minutes per MS raw file. By in-
creasing the amount of metagenomic sequence data for a single
sample, the total number of assigned spectra increased by 63%
(from 34,666 to 56,782) and the number of total identified non-
redundant (NR) peptides increased by 67% (from 9,618 to 16,055)
(Table 1, RM versus RMPS), resulting in a 54% increase in
protein identifications (3,394 to 5,233) when mapping these
peptides to a protein dataset generated from assembled reads for
the exact same metagenomic sample.
Other than limitations associated with computational resources,
there was also a concern that real peptides predicted from 454-
reads would be filtered out given a 2-peptide per protein minimum
filter (Table 2, top panel). Therefore, the filtering parameters were
readjusted with a deltCN 0.0, 1-peptide minimum, and a high
mass accuracy filter (610 ppm) for the SEQUEST RMPS
database searches for both 6a (Run 2 and 3) and 6b (Run 1 and
2). The identified peptides were then mapped back to the
predicted protein sequences derived from the assembled metage-
nomic sequences with a 2-peptide filter, resulting in an increase of
protein identifications, from 5,233 to 6,186 (Table 2, RMPS top
panel versus bottom panel). The filtering parameters were also
readjusted with a deltCN 0.0 and a high mass accuracy filter
(610 ppm) for the SEQUEST-RFM database searches for both
6a (Run 2 and 3) and 6b (Run 1 and 2). The protein identifications
also increased, from 3,431 to 3,706 (Table 2, RFM top versus
bottom panel). While this increase might seem minimal, there is
significantly less redundancy, less false positives, and no compu-
tational cost added to these filtering parameters. The false
discovery rate, using the same filtering parameters (deltCN 0.0,
1-peptide minimum and HM) for the RMPS database was 1.17%
for 6b (Table S3), however, these identified peptides ($1 peptide/
read) were mapped back to the predicted protein sequences derived
from the assembled metagenomic sequences using a post-database
$2-peptide/protein filter. Following application of this 2-peptide/
protein filter, the FDRs dropped to 0.1%–0.2% for 6b, Run 1 and 2
(Table S6).
De novo Peptide Sequencing
Two popular algorithms, PepNovo+ [37] and PEAKS [38],
were used to identify peptide sequences de novo from MS/MS
spectra collected from both samples, independent of all protein
sequence databases. Initially, the two algorithms were run
independently on the same raw MS data and samples as described.
The identified, high confidence consensus sequence tags ($3
residues) were acquired from each de novo algorithm. The de novo
consensus sequence tags (Text S1) for PEAKS and Pepnovo+ were
compared for every MS/MS to identify the partial ($3 residues)
and exact consensus sequence tags that would represent the most
confident PSMs identified by the two different de novo algorithms.
In this study, it was not our goal to compare the performance of
the two programs; instead, we want to combine the best results
from the two programs using their respective optimum parame-
ters. The final, representative de novo consensus tags were
compared to the previously mentioned SEQUEST results from
the RMPS sequence database searches that were filtered at a $1
peptide/read, deltCN 0.0, and high mass accuracy with a post-
database $2 peptide/protein filters. On average, ,593–724 MS/
MS spectra were assigned with a high confidence consensus
peptide sequence between the two de novo algorithms, but were not
assigned with the SEQUEST–RMPS database search (Fig. 3).
These de novo peptide sequences were mapped to protein sequences
predicted from assembled contigs with a 2-peptide minimum per
protein and compared to the peptides that were identified from the
SEQUEST-RMPS database searches. A total of 421 new, non-
redundant proteins were identified with the de novo sequenced
peptides for metagenome 6b, and 333 non-redundant proteins for
metagenome 6a; these proteins were not identified using
SEQUEST. Approximately 450 de novo sequenced peptides (non-
redundant) per sample could not be mapped to the matched
metagenomic sequence data.
Discussion
One of the major goals of MS-based proteomics is to com-
prehensively identify the protein complement of a given sample
(isolate, mixture, or community). The proteome(s) of microbial
communities are highly complex and pose numerous challenges for
MS experimentation and analysis. These challenges include the
dynamic range of peptide abundances and a number of informatics
hurdles, such as differentiation between closely related species,
identification of sequence polymorphisms, and global identification
of post-translational modifications. Many of the algorithms used in
MS/MS database searching are based on the assumption that a
protein is derived from a single organism with little sequence
diversity.However,theseassumptionsarenolongervalidinthe case
Table 2. Comparison of RFM and RMPS database results with
differentfilteringmetricsandapost-databasemappingstrategy.
Protein Database RFM RMPS
2-peptide, deltCN 0.08, HM Filter
Spectra Protein Spectra Protein
6a Run 2 3,246 1,154 6,542 1,761
6a Run 3 3,091 1,010 6,237 1,544
6b Run 1 2,639 637 5,212 973
6b Run 2 2,552 630 4,870 955
Total 11,528 3,431 22,861 5,233
1- or 2-peptide, deltCN 0.0, HM Filter
Spectra Protein Spectra Protein
Peptide Criteria $2 peptide $1 peptide
6a Run 2 3,541 1,252 7,497 2,069
6a Run 3 3,346 1,088 7,048 1,808
6b Run 1 2,879 686 5,881 1,182
6b Run 2 2,786 680 5,502 1,127
Total 12,552 3,706 25,928 6,186
Comparison of SEQUEST/DTASelect database search results, non-redundant
spectra and protein counts with different filtering parameters and HM, post-
database mapping of identified peptides to a protein dataset generated from
assembled reads for the same metagenomic sample.
doi:10.1371/journal.pone.0027173.t002
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strategies for improving metagenomic guided MS-based metapro-
teomic peptide-spectrum matching in complex samples.
It has become very clear that the quality of metagenomic se-
quence data and resulting protein sequence database has a
significant impact on community MS-based proteomics and the
ability to achieve deep proteome coverage. This study initially
explored how assembly and gene finding methods for metage-
nomic sequences affects peptide-spectrum matching. Our findings
suggest that predicting ORFs from an ab-initio gene finder on
metagenomic reads provides the best database for maximal MS/
MS assignment. While assembly of metagenomic data can greatly
reduce the necessary compute time for gene finding and database
searching, it essentially collapses sequence diversity; thus, it is sub-
optimal for maximal spectral assignment. Yet, introducing a
homology-based gene finding method (RFM) does not increase the
number of assigned spectra. Lastly, with an increase in sequence
coverage for a biological sample, our results suggest that predicted
protein sequence databases derived from matched metagenomic
sequenced reads (RMPS), increases the number of MS/MS
spectra, peptides, and protein identifications. In conclusion, ex-
panding the metagenomic sequence library for matched or related
samples improved peptide-spectrum matching. However, im-
provements in gene finding are equally important to maximize
protein identification and coverage.
As the matched metagenomic predicted protein sequence
database (RMPS) more accurately reflected the ‘‘true proteome’’,
previously unassigned high-quality spectra are now being
identified and provided greater proteomic depth. When these
results were compared to a standard bacterial isolate (e.g., E. coli)
with a well-curated genome, ,41,000 MS/MS spectra were
assigned to peptides (37% of total collected MS/MS) (data not
shown) using the same database searching filters ($2 peptide and
deltCN 0.08). This would suggest that underlying challenges are
still inhibiting the identification of a majority of spectra collected
from the community samples compared to that of a standard
bacterial isolate. The classification of acquired and assigned MS/
MS spectra and quantification of total identified peptides
suggested that the RMPS processing method provided the most
comprehensive assignment of MS/MS spectra.
Figure 3. Performance and comparison of de novo peptide sequencing results. Distribution of assigned spectra per de novo algorithm with
a predicted consensus sequence (partial and/or exact sequence match) among all three algorithms, PEAKS, PepNovo+, and SEQUEST. Identified
peptides from SEQUEST and RMPS sequence database were compared to the de novo predicted peptides for (A) 6a Run 2, (B) 6a Run 3, (C) 6b Run 1,
and (D) 6b Run 2.
doi:10.1371/journal.pone.0027173.g003
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read-based ORFs (e.g., RMPS processing method) and not
assigned from the contig-based ORFs (e.g., NM processing
method), we find that these ‘‘lost peptides’’ fall into three cate-
gories: (i) some reads are not assembled and therefore their protein
predictions are not in the contig-based ORF predictions, (ii)
because of SNPs and frameshifts, the peptides are 100% similar to
a predicted contig-based ORF, but are not 100% identical, and
(iii) some peptides were very different (,50% identical) or missing
from the contig-predicted ORF. A 6-frame translation protein
database was generated for sample 6a to capture all possible
candidate peptide sequences and searched against one MS
experiment (Run 2). However, routine use of this sequence
database is impractical due to the increased quantity of sequences
which directly correlates with an increased quantity of candidate
peptides, therefore, more scoring and prohibitively large search
times (,134 hrs per MS experiment) (data not shown). As
sequencing data generation increases, even a read-based strategy
could become unsustainable, which will only worsen as new larger
‘omic’ datasets become available.
Identifying the most reliable set of peptides from a MS-based
metaproteomic experiment can be complicated, as we have shown
that MS/MS assignments can vary and be assigned to different
peptide sequences with different protein databases. While filtering
on deltCN is a common practice for reducing false positives, this
type of filtering may (i) continue to include many ambiguous
peptides based on the different database predictions and (ii)
remove many legitimate peptides as a result of a highly redundant
database. Although filtering on deltCN and peptide-protein
matches has proven effective for single genome searching, these
filters decrease both precision and sensitivity in metagenomic
predicted sequence databases. As common filtering strategies have
proven to be less effective and practical for large-scale proteomics
studies (e.g., post-translational studies) [33], these and other
challenges will surface as the MS field moves towards sampling
more environmental communities. Alternatively, we propose that
when high mass accuracy is used in conjunction with other
filtering metrics, such as, cross correlation (XCorr) and enzyme
cleavage specificity, one can confidently identify the most com-
prehensive and reproducible set of PSMs and control false
positives adequately in a complex environmental community sam-
ple. As shown, this strategy greatly reduces the rate of ambiguous
peptide predictions thereby giving higher confidence to our final
peptide-protein identifications. Once peptides are identified and
mapped to metagenomic sequences, which have been assembled,
the subsequent use of a 2-peptide filter greatly reduces the num-
ber of false positives in protein discovery for complex microbial
environments.
Finally, de novo peptide sequencing can complement MS/MS
database searching to identify peptides absent in the protein
sequence database due to the limitations of the gene finding
algorithms or low metagenomic sequence coverage. We believe that
novel peptides were identified with high confidence in this study,
because these peptides were independently identified by two de novo
sequencing algorithms. However, there is no widely accepted
method for us to use for rigorously evaluating the FDRs of novel
peptides identifiedfrom our microbial community samples. Thus, de
novo sequencing results should be used with the caveat of uncertain
FDRs as supplement to database searching results [40].
By using a variety of MS filtering metrics, we were able to assess
the quality and accuracy of MS/MS peptide sequencing for each
MS experiment against four predicted protein sequence databases
derived from whole genome shotgun sequences. Our findings
suggest that: (i) proteomic data is twice as likely to match
metagenomic data derived from the same sample, (ii) although
unrelated metagenomic data may capture more sequence
diversity, large protein databases can create unreasonable
sequence redundancy, thereby hampering the ability to differen-
tiate real peptide-protein identifications, (iii) the percentage of
unassigned, high-quality MS/MS spectra decreases with increased
quality of metagenomic sequences, (iv) metagenomic data
processing, such as assembly and gene finding, affects the ability
to assign peptides to spectra, (v) MS filtering metrics can affect the
accuracy of peptide-spectrum matching, (vi) deeper metagenomic
sequencing coverage results in deeper coverage of matched
metaproteomes and (vii) de novo peptide sequencing can overcome
potential sequencing errors and provide evidence for novel
sequences not yet sequenced or not identified by database
searching methods. The high-quality unassigned MS/MS from
sequence-database searching would be ideal target spectra to
submit for de novo peptide sequencing whereby these sequences
could be mapped back to help refine the metagenome and identify
potential sequencing errors. Finally, this study illustrates how
common metagenomic processing methods (assembly and ORF
finding) and database construction can affect metaproteomics
search results.
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Figure S1 Accuracy Assessment by DTASelect Filtering. (a) For
each DTASelect peptide prediction search, the number of
identified spectra was calculated and compared using three
different parameter combinations, deltCN filtered results at a
deltCN of 0.08 only, both deltCN of 0.08 and HM (610 ppm),
and HM (610 ppm) only, where identified peptide sequences were
designated either ‘Consistent’ (solid gray) or ‘Inconsistent’
(diagonal stripes). (b) A VENN diagram with assignable spectra
for RFM, RFM_KG, NM, and NM_KG databases, filtered by
high mass accuracy, for both samples combined.
(EPS)
Table S1 Metagenomic sequencing metrics.
(XLS)
Table S2 Database dependent distribution of acquired full MS
and MS/MS and assigned MS/MS for samples 6a and 6b.
Unassigned MS/MS were parsed into either quality or poor
spectra.
(XLS)
Table S3 False discovery rates for sample 6b (Run 1) against six
different metagenomic-predicted sequence databases. The data-
base results were filtered at a 1-peptide level with and without high
mass accuracy.
(XLS)
Table S4 False discovery rates for sample 6b (Run 1) against six
different metagenomic-predicted sequence databases. The data-
base results were filtered at a 2-peptide level with and without high
mass accuracy.
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Table S5 Distribution of RFM_KG assigned PSMs for 6a (Run 2
and 3) and 6b (Run1 and 2). The assigned PSMs were distributed
into three different categories: RFM only, KG only, and RFM plus
KG based on their sequence uniqueness to each set of sequences. If
a PSM was unique to protein sequences in RFM, but was not
present inKG,the PSMwasclassifiedand categorized asRFMonly
andviceversa.IfaPSMwasfoundtomatchaproteininboth,RFM
and KG, the PSM was categorized as a shared spectrum.
(XLS)
Strategies for Metagenomic-Guided Community Proteomics
PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e27173Table S6 False discovery rates for sample 6b (Run 1 and 2)
against the RMPS database. An initial $1-peptide, deltCN 0.0,
and high mass accuracy (610 ppm) filter were applied to the read-
based identifications followed by a $2-peptide/protein post-
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